Augmedix Alpha and Beta Analysis
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Augmedix. It also helps investors analyze the systematic and unsystematic risks associated with investing in Augmedix over a specified time horizon. Remember, high Augmedix's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Augmedix's market risk premium analysis include:
Beta 0.91 | Alpha 2.23 | Risk 0.29 | Sharpe Ratio 0.33 | Expected Return 0.0954 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Augmedix |
Augmedix Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Augmedix market risk premium is the additional return an investor will receive from holding Augmedix long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Augmedix. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Augmedix's performance over market.| α | 2.23 | β | 0.91 |
Augmedix Fundamentals Vs Peers
Comparing Augmedix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Augmedix's direct or indirect competition across all of the common fundamentals between Augmedix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Augmedix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Augmedix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Augmedix to competition |
| Fundamentals | Augmedix | Peer Average |
| Return On Equity | -3.3 | -0.31 |
| Return On Asset | -0.31 | -0.14 |
| Profit Margin | (0.46) % | (1.27) % |
| Operating Margin | (0.64) % | (5.51) % |
| Current Valuation | 113.21 M | 16.62 B |
| Shares Outstanding | 49.43 M | 571.82 M |
| Shares Owned By Insiders | 1.50 % | 10.09 % |
Augmedix Opportunities
Augmedix Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | AI-Focused Healthcare Documentation Provider Augmedix Goes Private In 139M Deal | 07/19/2024 |
2 | The 3 Stocks Every Investor Should Be Selling in July | 07/25/2024 |
3 | STOCKHOLDER ALERT The MA Class Action Firm Investigates the Merger of Augmedix, Inc. AUGX | 07/30/2024 |
4 | Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024 | 08/06/2024 |
5 | AUGX Stock Earnings Augmedix Misses EPS, Misses Revenue for Q2 2024 | 08/13/2024 |
6 | Disposition of 21598 shares by Mcgraw Laurie of Augmedix subject to Rule 16b-3 | 08/28/2024 |
7 | Augmedix shareholders approve merger with Commure - Investing.com | 09/27/2024 |
8 | Disposition of 131250 shares by Emmanuel Krakaris of Augmedix subject to Rule 16b-3 | 10/02/2024 |
About Augmedix Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Augmedix or other delisted stocks. Alpha measures the amount that position in Augmedix has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Augmedix Upcoming Company Events
As portrayed in its financial statements, the presentation of Augmedix's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Augmedix's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Augmedix's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Augmedix. Please utilize our Beneish M Score to check the likelihood of Augmedix's management manipulating its earnings.
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Augmedix
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |